We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO Latin America Conference
September 4-5, 2018
BIO Investor Forum
October 17-18, 2018
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
October 17 - 18, 2018 | San Francisco, California
Satyen, a young entrepreneur, Co-founder & Chief Scientific Officer of Regrow, postgraduated in stem cell technology from University of Nottingham (UK). On returning to India, he set up India’s first GMP Certified Human Cell Processing Centre.
He is responsible for the research and development and regulatory affairs in his organization. Satyen along with his team launched India's first biological cell based drug for avascular necrosis of the hip in June 2017.
His company is one of the largest employers in stem cell industry in India with more than 25 scientists and 150 business professionals.
He has been a noted speaker in various Medical, Scientific & Industry Forums such as Cord Blood World Europe 2016, Stem cell & Regenerative Medicine Congress 2016 -London, BioAfrica Summit, Bio CEO Investor Conference- Newyork and ARM Cell & Gene meeting.
With all these attainments, he is chasing his long-term vision to be a global leader in delivering advanced cell therapeutics.
This speaker's sessions: